These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5223447)

  • 1. The similar pharmacologic effects of pentaborane, decaborane and reserpine.
    Weir FW; Meyers FH
    Ind Med Surg; 1966 Aug; 35(8):696-701. PubMed ID: 5223447
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxicology of boron hydrides--studies of alterations in tissue amines by toxic decaborane-14 (B10H14) and pentaborane-9 (B5H9) as modified by hydrazines and propynylamines. SAM-TR-66-112.
    Wykes AA; Landez JH
    Tech Rep SAM-TR; 1966 Nov; ():1-10. PubMed ID: 5298096
    [No Abstract]   [Full Text] [Related]  

  • 3. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
    Koe BK; Weissman A; Welch WM; Browne RG
    J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of reserpine on behavior and on brain concentrations of serotonin and norepinephrine in control rats and rats with hypothalamic lesions.
    Grabarits F; Harvey JA
    J Pharmacol Exp Ther; 1966 Sep; 153(3):401-11. PubMed ID: 5921526
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preclinical study of tricyclic antidepressive agents].
    Simon P
    Therapie; 1973; 28(2):209-23. PubMed ID: 4766355
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristics of the central action of sidnocarb].
    Anokhina IP; Zabrodin GD; Svirinovskiĭ IaE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(4):594-602. PubMed ID: 4825943
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma corticosterone changes following alterations in brain norepinephrine and serotonin.
    McKinney WT; Prange AJ; Majchowicz E; Schlesinger K
    Dis Nerv Syst; 1971 May; 32(5):308-13. PubMed ID: 4397134
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavioral neurochemistry of benzodiazepines.
    Stein L
    Arzneimittelforschung; 1980; 30(5a):868-73. PubMed ID: 6106487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats.
    Miller RT; Lau SS; Monks TJ
    Chem Res Toxicol; 1996 Mar; 9(2):457-65. PubMed ID: 8839050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VI. Catecholamine metabolism in the brain and adrenal medulla during addiction to morphine and in the early abstinence period.
    Maynert EW
    Res Publ Assoc Res Nerv Ment Dis; 1968; 46():89-95. PubMed ID: 5749391
    [No Abstract]   [Full Text] [Related]  

  • 11. Alterations of monoamine content by decaborane after monoamine oxidase inhibition by iproniazid. SAM-TR-67-72.
    Merritt JH; Sulkowski TS
    Tech Rep SAM-TR; 1967 Jul; ():1-6. PubMed ID: 5301200
    [No Abstract]   [Full Text] [Related]  

  • 12. Brain serotonin and norepinephrine after convulsions and reserpine.
    Feighner JP; Lao L; King LJ; Ross WJ
    J Neurochem; 1972 Mar; 19(3):905-7. PubMed ID: 5030993
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of metoclopramide on the cardiovascular system and its regulatory vegetative nervous system].
    Marmo E; Imperatore A; Di Giacomo S
    Clin Ter; 1969 Dec; 51(6):509-39. PubMed ID: 5371378
    [No Abstract]   [Full Text] [Related]  

  • 14. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The toxicity and pharmacologic properties of rifamycin SV].
    Gol'dberg LE; Filippos'iants ST; Muraveiskaia VS; Vertogradova TP; Belova IP
    Antibiotiki; 1974 Apr; 19(4):344-50. PubMed ID: 4463873
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent advances in the pharmacology of tetrahydrocannabinols.
    Shideman FE
    Nihon Yakurigaku Zasshi; 1971 Sep; 46(5):113P-115P. PubMed ID: 5003899
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective protection of 5-hydroxytryptamine stores against the action of reserpine by treatment with 5-hydroxytryptophan.
    Carlsson A
    J Pharm Pharmacol; 1967 Nov; 19(11):783-4. PubMed ID: 4383709
    [No Abstract]   [Full Text] [Related]  

  • 18. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective protection of serotonin stores against the action of reserpine by -methyl-5-hydroxytryptpohan pretreatment.
    Lahti RA; Platz PA
    Biochem Pharmacol; 1969 Oct; 18(10):2363-9. PubMed ID: 4397869
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological analysis of shaking behavior induced by enkephalins, thyrotropin-releasing hormone or serotonin in rats: evidence for different mechanisms.
    Drust EG; Connor JD
    J Pharmacol Exp Ther; 1983 Jan; 224(1):148-54. PubMed ID: 6401333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.